One Week Versus Three Week in Adjuvant Radiotherapy in Breast Cancer

Background:Moderate three week hypofractionated adjuvant radiotherapy schedule is a standard care in breast cancers. A five day schedule has been demonstrated to be iso-toxic as a standard three week schedule. Recently studies have also demonstrated the safety and feasibility of simultaneous integrated boost in this setting. This randomized trial will investigate if a one-week course of hypofractionated breast radiotherapy is non-inferior to a three week course. Aim: To determine if one-week schedule of adjuvant radiotherapy in breast cancer is non-inferior to a three week schedule. Primary

Trial Details

NCT ID
NCT03788213
Phase
NA
Sponsor
Tata Medical Center
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • 3 week RT
  • 1 week RT
Locations (sample)
  • Kolkata, West Bengal, India|22.56263,88.36304

Key Eligibility Criteria

  • Histologically or cytologically confirmed invasive breast cancers
  • Age \> 18 years
  • ECOG performance status : 0 - 3
  • Underwent curative intent surgery for the breast cancer with complete microscopic resection either in the form of a mastectomy or breast conservati…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →